The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
M2-type exosomes nanoparticles for rheumatoid arthritis therapy via macrophage re-polarization
Abstract
Imbalance between the activities of pro-inflammatory M1 and anti-inflammatory M2 macrophages in rheumatoid arthritis (RA) induces synovial inflammation and autoimmunity, leading to joint damage. Here we encapsulated a plasmid DNA encoding the anti-inflammatory cytokine interleukin-10 (IL-10 pDNA) and the chemotherapeutic drug betamethasone sodium phosphate (BSP) into biomimetic vector M2 exosomes (M2 Exo) derived from M2-type macrophages. We demonstrate that the loaded exosomes target and reduce inflammation for combined therapy against RA. The in vitro efficiency of the M2 Exo/pDNA/BSP co-delivery system was attributed to the synergistic effect of IL-10 pDNA and BSP, which also promoted M1-to-M2 macrophage polarization by reducing the secretion of pro-inflammatory cytokines (IL-1β, TNF-α) and increasing the expression of IL-10 cytokine. In a mouse model of RA, M2 Exo/pDNA/BSP showed good accumulation at inflamed joint sites, high anti-inflammatory activity, and potent therapeutic effect. The delivery system was non-toxic both in vitro and in vivo. Thus, this system may serve as a promising biocompatible drug carrier and anti-inflammatory agent for RA treatment based on M1-to-M2 macrophage re-polarization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The biology , function , and biomedical applications of exosomes
Kalluri, R., & LeBleu, V. S. (2020) · Science · doi:10.1126/science.aau6977 · Cited by 10,770
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Smolen, J. S., Aletaha, D., & McInnes, I. B. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30173-8 · Cited by 4,870
Macrophage activation and polarization
Martinez, F. O. (2008) · Frontiers in Bioscience · doi:10.2741/2692 · Cited by 3,160
Yunna, C., Mengru, H., Lei, W., & Weidong, C. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173090 · Cited by 2,454
Brand, D. D., Latham, K. A., & Rosloniec, E. F. (2007) · Nature Protocols · doi:10.1038/nprot.2007.173 · Cited by 1,418
Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages
Ip, W. K. E., Hoshi, N., Shouval, D. S., Snapper, S., & Medzhitov, R. (2017) · Science · doi:10.1126/science.aal3535 · Cited by 1,375
Zhang, Y., Bi, J., Huang, J., Tang, Y., Du, S., & Li, P. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s264498 · Cited by 1,323
Exosome Theranostics: Biology and Translational Medicine
He, C., Zheng, S., Luo, Y., & Wang, B. (2018) · Theranostics · doi:10.7150/thno.21945 · Cited by 1,249
Using exosomes, naturally-equipped nanocarriers, for drug delivery
Batrakova, E. V., & Kim, M. S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.030 · Cited by 1,041
Nanomedicine(s) under the Microscope
Duncan, R., & Gaspar, R. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200394t · Cited by 981
M2b macrophage polarization and its roles in diseases
Wang, L.-X., Zhang, S.-X., Wu, H.-J., Rong, X.-L., & Guo, J. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ru1018-378rr · Cited by 884
Long-term side effects of glucocorticoids
Oray, M., Abu Samra, K., Ebrahimiadib, N., Meese, H., & Foster, C. S. (2016) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2016.1140743 · Cited by 869
Proteomic profiling of exosomes: Current perspectives
Simpson, R. J., Jensen, S. S., & Lim, J. W. E. (2008) · PROTEOMICS · doi:10.1002/pmic.200800109 · Cited by 857
Macrophages in inflammation, repair and regeneration
Oishi, Y., & Manabe, I. (2018) · International Immunology · doi:10.1093/intimm/dxy054 · Cited by 734
Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes
Wahlgren, J., Karlson, T. D. L., Brisslert, M., Vaziri Sani, F., Telemo, E., Sunnerhagen, P., & Valadi, H. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks463 · Cited by 715
M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon Cancer
Lan, J., Sun, L., Xu, F., Liu, L., Hu, F., Song, D., Hou, Z., Wu, W., Luo, X., Wang, J., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-0014 · Cited by 643
Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain
Yuan, D., Zhao, Y., Banks, W. A., Bullock, K. M., Haney, M., Batrakova, E., & Kabanov, A. V. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.07.011 · Cited by 607
Exosome-mediated delivery of siRNA in vitro and in vivo
El-Andaloussi, S., Lee, Y., Lakhal-Littleton, S., Li, J., Seow, Y., Gardiner, C., Alvarez-Erviti, L., Sargent, I. L., & Wood, M. J. A. (2012) · Nature Protocols · doi:10.1038/nprot.2012.131 · Cited by 601
Kim, J., Kim, H. Y., Song, S. Y., Go, S.-H., Sohn, H. S., Baik, S., Soh, M., Kim, K., Kim, D., Kim, H.-C., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b08785 · Cited by 550
Therapeutic Mechanisms of Glucocorticoids
Vandewalle, J., Luypaert, A., De Bosscher, K., & Libert, C. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.10.010 · Cited by 548
Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson’s disease
Qu, M., Lin, Q., Huang, L., Fu, Y., Wang, L., He, S., Fu, Y., Yang, S., Zhang, Z., Zhang, L., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.035 · Cited by 543
Self-citationOne Hormone, Two Actions: Anti- and Pro-Inflammatory Effects of Glucocorticoids
Cruz-Topete, D., & Cidlowski, J. A. (2015) · Neuroimmunomodulation · doi:10.1159/000362724 · Cited by 454
Trehalose prevents aggregation of exosomes and cryodamage
Bosch, S., de Beaurepaire, L., Allard, M., Mosser, M., Heichette, C., Chrétien, D., Jegou, D., & Bach, J.-M. (2016) · Scientific Reports · doi:10.1038/srep36162 · Cited by 393
Genetically Engineered Microvesicles Carrying Suicide mRNA/Protein Inhibit Schwannoma Tumor Growth
Mizrak, A., Bolukbasi, M. F., Ozdener, G. B., Brenner, G. J., Madlener, S., Erkan, E. P., Ströbel, T., Breakefield, X. O., & Saydam, O. (2013) · Molecular Therapy · doi:10.1038/mt.2012.161 · Cited by 337
M1 and M2 macrophage polarization and potentially therapeutic naturally occurring compounds
Wang, Y., Smith, W., Hao, D., He, B., & Kong, L. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.02.050 · Cited by 330
Self-citationRoute to Rheumatoid Arthritis by Macrophage-Derived Microvesicle-Coated Nanoparticles
Li, R., He, Y., Zhu, Y., Jiang, L., Zhang, S., Qin, J., Wu, Q., Dai, W., Shen, S., Pang, Z., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.8b03439 · Cited by 328
Wang, H., Sui, H., Zheng, Y., Jiang, Y., Shi, Y., Liang, J., & Zhao, L. (2019) · Nanoscale · doi:10.1039/c9nr01255a · Cited by 324
Exosomes as novel bio-carriers for gene and drug delivery
Jiang, X.-C., & Gao, J.-Q. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.02.038 · Cited by 321
Macrophages and their products in rheumatoid arthritis
Szekanecz, Z., & Koch, A. E. (2007) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32805e87ae · Cited by 308
Exosomes as nucleic acid nanocarriers
van den Boorn, J. G., Daßler, J., Coch, C., Schlee, M., & Hartmann, G. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.06.011 · Cited by 277
Wu, G., Zhang, J., Zhao, Q., Zhuang, W., Ding, J., Zhang, C., Gao, H., Pang, D., Pu, K., & Xie, H. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201913700 · Cited by 269
Jain, S., Tran, T.-H., & Amiji, M. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.05.028 · Cited by 250
The many facets of macrophages in rheumatoid arthritis
Siouti, E., & Andreakos, E. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.03.029 · Cited by 248
Dai, Y., Wang, S., Chang, S., Ren, D., Shali, S., Li, C., Yang, H., Huang, Z., & Ge, J. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.02.007 · Cited by 248
Self-citationWang, Q., Jiang, H., Li, Y., Chen, W., Li, H., Peng, K., Zhang, Z., & Sun, X. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.01.008 · Cited by 213
Self-citationYan, F., Zhong, Z., Wang, Y., Feng, Y., Mei, Z., Li, H., Chen, X., Cai, L., & Li, C. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00675-6 · Cited by 197
Self-citationPolarization of Rheumatoid Macrophages by TNF Targeting Through an IL-10/STAT3 Mechanism
Degboé, Y., Rauwel, B., Baron, M., Boyer, J.-F., Ruyssen-Witrand, A., Constantin, A., & Davignon, J.-L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00003 · Cited by 174
Barnes, P. J. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_62 · Cited by 168
A brain somatic RHEB doublet mutation causes focal cortical dysplasia type II
Zhao, S., Li, Z., Zhang, M., Zhang, L., Zheng, H., Ning, J., Wang, Y., Wang, F., Zhang, X., Gan, H., et al. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0277-4 · Cited by 166
Self-citationTang, T.-T., Lv, L.-L., Wang, B., Cao, J.-Y., Feng, Y., Li, Z.-L., Wu, M., Wang, F.-M., Wen, Y., Zhou, L.-T., et al. (2019) · Theranostics · doi:10.7150/thno.33520 · Cited by 163
Self-citationQuan, L., Zhang, Y., Crielaard, B. J., Dusad, A., Lele, S. M., Rijcken, C. J. F., Metselaar, J. M., Kostková, H., Etrych, T., Ulbrich, K., et al. (2014) · ACS Nano · doi:10.1021/nn4048205 · Cited by 160
The multiple facets of glucocorticoid action in rheumatoid arthritis
Baschant, U., Lane, N. E., & Tuckermann, J. P. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.166 · Cited by 151
Recent advances in nanomedicines for the treatment of rheumatoid arthritis
Wang, Q., & Sun, X. (2017) · Biomaterials Science · doi:10.1039/c7bm00254h · Cited by 145
Exosomes: Nanoparticulate tools for RNA interference and drug delivery
Shahabipour, F., Barati, N., Johnston, T. P., Derosa, G., Maffioli, P., & Sahebkar, A. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25766 · Cited by 126
Yao, M., Zhang, W., Ma, W., Liu, Q., Xing, L., & Zhao, G.-F. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0255-x · Cited by 109
Deng, F., & Miller, J. H. (2019) · Journal of Histotechnology · doi:10.1080/01478885.2019.1646984 · Cited by 108
Exosome membrane-modified M2 macrophages targeted nanomedicine: Treatment for allergic asthma
Pei, W., Li, X., Bi, R., Zhang, X., Zhong, M., Yang, H., Zhang, Y., & Lv, K. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.024 · Cited by 98
Gong, T., Tan, T., Zhang, P., Li, H., Deng, C., Huang, Y., Gong, T., & Zhang, Z. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120296 · Cited by 96
Self-citationYan, F., Li, H., Zhong, Z., Zhou, M., Lin, Y., Tang, C., & Li, C. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s219413 · Cited by 91
Self-citationThe novel target:exosoms derived from M2 macrophage
Hou, Y., Liu, Y., Liang, S., Ding, R., Mo, S., Yan, D., & Li, D. (2020) · International Reviews of Immunology · doi:10.1080/08830185.2020.1800687 · Cited by 28
Cited by
Macrophage polarization: an important role in inflammatory diseases
Luo, M., Zhao, F., Cheng, H., Su, M., & Wang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1352946 · Cited by 468
Self-citationHybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications
Mondal, J., Pillarisetti, S., Junnuthula, V., Saha, M., Hwang, S. R., Park, I.-K., & Lee, Y.-K. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.12.027 · Cited by 416
Controlling the biodistribution and clearance of nanomedicines
Cabral, H., Li, J., Miyata, K., & Kataoka, K. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00138-1 · Cited by 303
Wu, Y., Wan, S., Yang, S., Hu, H., Zhang, C., Lai, J., Zhou, J., Chen, W., Tang, X., Luo, J., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01746-6 · Cited by 301
Exosome-Based Drug Delivery: Translation from Bench to Clinic
Koh, H. B., Kim, H. J., Kang, S.-W., & Yoo, T.-H. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15082042 · Cited by 259
Metadata
- Authors
- Li, H., Feng, Y., Zheng, X., Jia, M., Mei, Z., Wang, Y., Zhang, Z., Zhou, M., & Li, C.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2022-01
- Volume
- 341
- Pages
- 16-30
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W3212827607
- Cited by
- 259
- References
- 52
- FWCI
- 9.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.